Corporate Development Manager

AliveDx•Chicago, IL

About The Position

AliveDx is recruiting a Corporate Development Manager for its Alba Strategic Partnerships and New Ventures team, based in the United States, preferably on the East Coast. This is a full-time, permanent position working 40 hours per week, with travel required. The role drives Alba’s inorganic growth strategy by identifying, evaluating, and executing strategic acquisitions, licensing opportunities, and new business ventures. The manager oversees opportunities from initial assessment and deal evaluation through transaction completion and post-acquisition integration, ensuring alignment with strategic objectives and sustainable business value. Working with Finance, Legal, Strategic Marketing, Product Management, R&D, Operations, external advisors, and potential partners, the manager leads due diligence, develops financial and commercial assessments, and supports transaction execution and integration. Responsibilities include maintaining a screened pipeline mapped to growth pillars; preparing opportunity briefs and deal theses; managing cross-functional diligence; developing deal models with Finance; coordinating transaction structuring, negotiations, advisors, and Legal; planning and steering integration; tracking licensing obligations and earn-outs; and reporting deal performance against approved theses. The manager brings inorganic opportunities to G0 at the Portfolio Governance Board and runs a monthly Corp Dev / M&A Review.

Requirements

Bachelor’s degree in Finance, Business, Life Sciences, or a related discipline.
Significant experience in corporate development, transaction services, investment banking, or corporate strategy.
Demonstrable experience personally leading due diligence workstreams and developing financial models for acquisition opportunities.
Experience managing complex transactions and working with senior stakeholders, external advisors, and potential business partners.
Strong financial modelling and valuation skills, including the ability to develop and defend investment cases and financial assessments.
Ability to assess financial, commercial, technical, and operational risks and translate findings into clear recommendations.
Ability to navigate ambiguity, manage sensitive information, and maintain strict confidentiality during complex transactions.
Strong communication and influencing skills, with the ability to build credibility and effective relationships with senior leadership, potential acquisition targets, external advisors, and other stakeholders.
Highly organised, with the ability to manage multiple complex workstreams and competing priorities.
Confident decision-maker able to translate complex due diligence findings into clear, actionable recommendations.
Collaborative and pragmatic approach, with the ability to work effectively across cross-functional teams and influence outcomes.

Nice To Haves

MBA, CFA, or equivalent professional qualification.
Experience in the life sciences sector.
Knowledge of the IVD or diagnostics sector.

Responsibilities

Maintain the corporate development pipeline, including screened targets and licensing opportunities mapped to growth pillars, with an informed view on timing and price.
Prepare an opportunity brief for each live opportunity, covering strategic fit, value creation, kill-risks, and integration burden.
Run end-to-end financial, technical, regulatory/quality, commercial, and supply diligence using a managed request list, and log findings against the deal thesis.
Build deal models with Finance using the standard workbook, and own the sourcing of synergy and integration-cost assumptions.
Drive transactions toward signature, support negotiations and transaction structuring, and coordinate external advisors and Legal.
Plan integration before signing, including ownership, milestones, and day-one requirements, and steer execution through handover to line management.
Carry acquired pre-launch products into the standard stage-gate process.
Track post-close licensing obligations and earn-outs, and report deal performance against the thesis at 12 and 24 months.
Bring every inorganic option to G0 at the Portfolio Governance Board and own deal theses, diligence, and integration plans.
Run a monthly Corp Dev / M&A Review.